Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases

被引：0
|
作者：
Maria Fasshauer
Michael Borte
Michaela Bitzenhofer
Christine Pausch
David Pittrow
Michelle Park
André Gladiator
Peter Jandus
机构：
[1] Hospital St. Georg,Hospital for Children and Adolescents
[2] Academic Teaching Hospital of the University of Leipzig,ImmunoDeficiencyCenter Leipzig (IDCL)
[3] Hospital St. Georg,Division of Allergology and Clinical Immunology, Department of Pneumology
[4] Academic Teaching Hospital of the University of Leipzig,Institute for Clinical Pharmacology
[5] University Hospital Berne (Inselspital Bern),Division of Clinical Immunology and Allergy, Department of Medicine
[6] GWT-TUD GmbH,undefined
[7] Innovation Centre Real World Evidence,undefined
[8] Technical University,undefined
[9] Takeda Development Center Americas,undefined
[10] Inc.,undefined
[11] Takeda Pharmaceuticals International AG,undefined
[12] University Hospital and Medical Faculty,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Antibody deficiency syndromes; Ig20Gly; Immunoglobulin replacement therapy; Inborn errors of immunity; Observational; Primary immunodeficiency diseases; SCIG; Subcutaneous immunoglobulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5168 / 5187
页数：19
相关论文
共 50 条
  • [31] Patient experience with subcutaneous immunoglobulin 20%, Ig20Gly, for primary immunodeficiency diseases: a prespecified post hoc analysis of combined data from 2 pivotal trials
    Meckley, Lisa M.
    Wu, Yanyu
    Ito, Diane
    Berner, Todd
    McCoy, Barbara
    Yel, Leman
    BMC IMMUNOLOGY, 2020, 21 (01)
  • [32] Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency
    Fasth, Anders
    Nystrom, Jeanette
    ACTA PAEDIATRICA, 2007, 96 (10) : 1474 - 1478
  • [33] The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases
    Azizi, Gholamreza
    Abolhassani, Hassan
    Asgardoon, Mohammad Hosein
    Rahnavard, Javad
    Dizaji, Majid Zaki
    Yazdani, Reza
    Mohammadi, Javad
    Aghamohammadi, Asghar
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2016, 16 (02) : 80 - 88
  • [34] Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
    John B. Hagan
    Mary B. Fasano
    Sheldon Spector
    Richard L. Wasserman
    Isaac Melamed
    Mikhail A. Rojavin
    Othmar Zenker
    Jordan S. Orange
    Journal of Clinical Immunology, 2010, 30 : 734 - 745
  • [35] Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
    Hagan, John B.
    Fasano, Mary B.
    Spector, Sheldon
    Wasserman, Richard L.
    Melamed, Isaac
    Rojavin, Mikhail A.
    Zenker, Othmar
    Orange, Jordan S.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (05) : 734 - 745
  • [36] Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients with Primary Immunodeficiency
    Hagan, J.
    Fasano, M. B.
    Spector, S.
    Wasserman, R. L.
    Melamed, I.
    Rojavin, M. A.
    Zenker, O.
    Orange, J. S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB140 - AB140
  • [37] Use of Home-Based Subcutaneous Immunoglobulin Therapy in Elderly Patients With Primary Immunodeficiency Diseases
    Guthrie, Robert M.
    POSTGRADUATE MEDICINE, 2013, 125 (01) : 169 - 171
  • [38] Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases (vol 6, pg 169, 2013)
    Kanegane, Hirokazu
    Imai, Kohsuke
    Yamada, Masafumi
    Takada, Hidetoshi
    Ariga, Tadashi
    Bexon, Martin
    Rojavin, Mikhail
    Hu, Wilson
    Kobayashi, Midori
    Lawo, John-Philip
    Nonoyama, Shigeaki
    Hara, Toshiro
    Miyawaki, Toshio
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (04) : 520 - 520
  • [39] High treatment satisfaction with Hizentra, a 20% subcutaneous immunoglobulin (SCIG): real-world survey data
    Romano, Jacob M.
    Mallick, Rajiv
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB267 - AB267
  • [40] TREATMENT PREFERENCE AMONG PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) ON INVESTIGATIONAL 20% SUBCUTANEOUS IMMUNOGLOBULIN THERAPY
    Berner, T.
    Meckley, L.
    Yel, L.
    Engl, W.
    Ito, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S98 - S99
12345